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ABSTRACT 
 
Background: Chronic kidney disease (CKD) after liver (LT) or intestinal (IT) transplantation may 
decrease patient survival. Calcineurin inhibitors (CNI) play a major role in its development.  
Aims: Describe long term renal function and risk factors for developing CKD in adults and children after 
LT and IT. Investigate if CNI discontinuation in adults after LT improves renal function.  
Methods: GFR was measured (GFRm) with either Iohexol or 51-Cr EDTA-clearance in both adults and 
children at different intervals before and after LT and IT.  
Results: After LT in adults (n=152) (I), GFRm decreased with 42% after10 years. Prevalence of CKD 
increased over time: 12% at 5 years and 29% at 10 years. Eight patients (5%) required renal replacement 
therapy (RRT). Baseline GFRm correlated poorly with late renal function. GFRm at 3 months post-LT 
correlated well with GFRm at 5 years and GFRm below30 ml/min/1.73m2 at 3 months was a risk factor 
for CKD at 5 years.  After IT (II) CKD was almost universal. RRT was required in 20% of the patients. 
Calculated GFR (MDRD equation) overestimated GFRm with 30-40%. Children (n=36) undergoing LT 
(III) stabilized their renal function after an initial decline. None required RRT. Age above 2 years at LT, 
hepatic malignancies or metabolic liver diseases as the cause for LT were risk factors for developing 
CKD. A CNI discontinuation protocol (IV) in 25 adult patients with severe CKD was used with either 
mycophenolate mofetil (MMF ) (n=13) or sirolimus (SRL) (n=12). Baseline GFRm (n=25) was 31+/-8 
ml/min/1.73m2. At 3 months GFRm (n=23) increased to 40+/-10 ml/min/1.73m2 (p=0.0001). There was 
no significant difference when comparing the MMF and the SRL study arms. Patients (n=8) with baseline 
GFRm below 30 ml (CKD stage IV) increased GFRm at one year with 63% (p=0.003). Patients in the 
SRL group presented a higher incidence of oral ulcerations and hypertriglyceridemia. Two deaths were 
reported both probably unrelated to the change in immunosuppression. No biopsy proven rejection 
episodes occurred.  
Conclusion: CKD is a frequent complication after LT and IT. Early renal function may identify patients at 
risk of developing CKD. CNI discontinuation under the protection of either MMF or SRL was safe and 
GFRm increased significantly under the observational period.  
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